
Apr 24, 2025, 14:49
Feasibility, reliability and validity of smartphone administered cognitive ecological momentary assessments in breast cancer survivors
NeuroUX shared a post on LinkedIn:
“New paper alert!
This study demonstrates the feasibility, reliability, and validity of NeuroUX‘s mobile cognitive tests for evaluating cancer-related cognitive impairments in breast cancer survivors.
Over an 8-week period, participants completed smartphone-based cognitive tests with high adherence (87.3%) and high satisfaction (mean 87%). These findings highlight the value of NeuroUX for real-world cognitive monitoring in oncology.
Congratulations to the research team on this important work!
Read the full paper here.”
Authors: Ashley M. Henneghan et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 24, 2025, 14:42
Apr 24, 2025, 14:07
Apr 24, 2025, 14:03
Apr 24, 2025, 13:55
Apr 24, 2025, 13:48
Apr 24, 2025, 13:34